Does eFFECTOR Therapeutics, Inc. (EFTR) Have the Potential to Rally 814.53% as Wall Street Analysts Expect?

Shares of eFFECTOR Therapeutics, Inc. (EFTR) have gained 0.1% over the past four weeks to close the last trading session at $11.70, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $107 indicates a potential upside of 814.5%.The average comprises three short-term price targets ranging from a low of $21 to a high of $175, with a standard deviation of $78.56. While the lowest estim ...